Get email updates from SABCSMeetingNews.org
Subscribe to get regular news updates from SABCS.org and SABCS Meeting News.
DECEMBER 6–10, 2022
Henry B. Gonzalez Convention Center
|
San Antonio, TX
-
Panel of experts to discuss advances in radiotherapy technologies, techniques for breast cancer
Wendy A. Woodward, MD, PhD, leads a session on Friday looking at technological advances in radiation oncology and the impact on both patients and clinicians.
-
Session to review latest data on the impact of targeting the tumor microenvironment in breast cancer
Diana M. Cittelly, PhD, will moderate a session on Friday looking at how the tumor microenvironment has emerged as a critical driver of tumor progression.
-
Advances in Pregnancy Associated Breast Cancer: Presenter Profile
Ann Partridge, MD, MPH, discusses her presentation on special treatment issues in Friday’s educational session on PABC.
-
Expert who changed the standard of breast cancer care honored with the Brinker Award for Scientific Distinction in Clinical Research
Norman Wolmark, MD, FACS, FRCSC, will receive the Brinker Award for Scientific Distinction in Clinical Research on Friday, and will deliver the lecture “The Contribution of NSABP Clinical Trials to the Management of Early Breast Cancer: PAST AS PROLOGUE.”
-
General Session 2 features latest findings from DESTINY-Breast02/03, TRIO-US B-12 TALENT trials
Wednesday’s General Session included data from three trials looking at the use of the antibody drug conjugate trastuzumab deruxtecan (T-DXd) in HER2-positive metastatic and HER-2-low, HR-positive early-stage breast cancer.
-
Osborne Symposium highlights growing understanding of HER2, ER crosstalk
C. Kent Osborne, MD, opened a session named in his honor on Wednesday as experts discussed the interplay between estrogen receptors and HER2 signaling pathways.
-
McGuire Lecturer, Jeffrey Rosen, PhD, reviews work with preclinical models in breast cancer research
Jeffrey Rosen, PhD, a pioneer of mouse modeling and mouse mammary tumorigenesis, received the William L. McGuire Memorial Lecture Award.
-
Debate to weigh differences, similarities of CDK4/6 inhibitors
Ruth O’Regan, MD, and Debra Patt, MD, PhD, MBA, will take sides on the impacts of CDK4/6 inhibitors during a Thursday morning debate session.
-
Panel to discuss evolving role of liquid biopsies in breast cancer treatment and research
Nicholas Turner, MD, PhD, will moderate a Thursday afternoon session that will provide an update on the current uses of liquid biopsies in metastatic disease as well as growing applications for ctDNA in clinical trials.
-
Management of Hereditary Risk: Moderate-Risk Genes and New Approaches: Presenter Profiles
Madeleine M.A. Tilanus-Linthorst, MD, PhD, and Joanne Kotsopoulos, MSc, PhD, preview their Thursday afternoon presentations.